EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer - Archive ouverte HAL

Documentation
French (FR)

English (EN)

Journal Articles Cancer Letters Year : 2014

EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer

(1) , (1) , (1) , (1)

1

François Bertucci

Function : Author
PersonId : 753650
IdHAL : francois-bertucci
ORCID : 0000-0002-0157-0959

Centre de Recherche en Cancérologie de Marseille

Pascal Finetti

Function : Author
PersonId : 753338
IdHAL : pascal-finetti
ORCID : 0000-0002-2674-3123

Centre de Recherche en Cancérologie de Marseille

Patrice Viens

Function : Author

Centre de Recherche en Cancérologie de Marseille

Daniel Birnbaum

Function : Author
PersonId : 801231
ORCID : 0000-0001-7920-9883
IdRef : 092728782

Centre de Recherche en Cancérologie de Marseille

Domains

Life Sciences [q-bio] Cancer

François Bertucci : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-03623754

Submitted on : Tuesday, March 29, 2022-7:06:53 PM

Last modification on : Friday, March 24, 2023-2:53:26 PM

Dates and versions

hal-03623754 , version 1 (29-03-2022)

Identifiers

HAL Id : hal-03623754 , version 1
DOI : 10.1016/j.canlet.2014.09.014

Cite

François Bertucci, Pascal Finetti, Patrice Viens, Daniel Birnbaum. EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer. Cancer Letters, 2014, 355 (1), pp.70-75. ⟨10.1016/j.canlet.2014.09.014⟩. ⟨hal-03623754⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRCM

5 View

0 Download

Altmetric

Share